{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:52:45Z","timestamp":1774021965438,"version":"3.50.1"},"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1 I21 RX002069-01"],"award-info":[{"award-number":["1 I21 RX002069-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1 I21 RX002876-01"],"award-info":[{"award-number":["1 I21 RX002876-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002267"],"award-info":[{"award-number":["BX002267"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N01HHSN 271201300031"],"award-info":[{"award-number":["N01HHSN 271201300031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P50 AG005138-31"],"award-info":[{"award-number":["P50 AG005138-31"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG034087"],"award-info":[{"award-number":["AG034087"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG053446"],"award-info":[{"award-number":["AG053446"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG051545"],"award-info":[{"award-number":["AG051545"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206547","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T17:44:38Z","timestamp":1541094278000},"page":"e0206547","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer\u2019s disease and normalized by treatment with anti-diabetic agents"],"prefix":"10.1371","volume":"13","author":[{"given":"P.","family":"Katsel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4640-6239","authenticated-orcid":true,"given":"P.","family":"Roussos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Beeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Gama-Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5860-2512","authenticated-orcid":true,"given":"V.","family":"Haroutunian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2012-120106","article-title":"Changes in glycemic control are associated with changes in cognition in non-diabetic elderly","volume":"30","author":"R Ravona-Springer","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000265552","article-title":"Diabetes is associated with increased rate of cognitive decline in questionably demented elderly","volume":"29","author":"R Ravona-Springer","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"J Janson","year":"2004","journal-title":"Diabetes"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-150307","article-title":"Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition","volume":"47","author":"TS Salameh","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/db06-0879","article-title":"The effect of borderline diabetes on the risk of dementia and Alzheimer\u2019s disease","volume":"56","author":"W Xu","year":"2007","journal-title":"Diabetes"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.2337\/db10-0539","article-title":"Accelerated progression from mild cognitive impairment to dementia in people with diabetes","volume":"59","author":"W Xu","year":"2010","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin Resistance and Alzheimer\u2019s Disease: Bioenergetic Linkages","volume":"9","author":"BJ Neth","year":"2017","journal-title":"Frontiers in aging neuroscience"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/dc14-2043","article-title":"On the interplay of microvasculature, parenchyma, and memory in type 2 diabetes","volume":"38","author":"FC van Bussel","year":"2015","journal-title":"Diabetes Care"},{"issue":"20","key":"ref9","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/01.wnl.0000435561.00234.ee","article-title":"Higher glucose levels associated with lower memory and reduced hippocampal microstructure","volume":"81","author":"L Kerti","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.diabres.2011.07.002","article-title":"Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes","volume":"94","author":"K Hayashi","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"WQ Zhao","year":"2008","journal-title":"FASEB J"},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"FG De Felice","year":"2014","journal-title":"Diabetes"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","article-title":"Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels","volume":"12","author":"HH Ruiz","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","article-title":"Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer\u2019s disease: interactions with apolipoprotein E genotype","volume":"28","author":"S Craft","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease","volume":"6","author":"ME Risner","year":"2006","journal-title":"PharmacogenomicsJ"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2337\/diacare.29.02.06.dc05-1626","article-title":"Improving metabolic control leads to better working memory in adults with type 2 diabetes","volume":"29","author":"CM Ryan","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"Metformin, other antidiabetic drugs, and risk of Alzheimer\u2019s disease: a population-based case-control study","volume":"60","author":"P Imfeld","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2011.12.022","article-title":"Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci","volume":"90","author":"R Saxena","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"SE Arnold","year":"2018","journal-title":"Nature reviews Neurology"},{"issue":"49","key":"ref20","first-page":"34893","article-title":"Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats","volume":"274","author":"W Zhao","year":"1999","journal-title":"JBiolChem"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/dom.12969","article-title":"Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system","volume":"19","author":"RS Zimmerman","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"460","key":"ref22","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam6836","article-title":"Placing the nuclear pore in the metformin mechanism of action","volume":"10","author":"NR Gough","year":"2017","journal-title":"Sci Signal"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/dc15-2671","article-title":"Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy","volume":"39","author":"J Sanahuja","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer\u2019s Disease Biomarkers: A Pilot Clinical Trial","volume":"57","author":"S Craft","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"S Craft","year":"2004","journal-title":"Lancet Neurol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/01.wnl.0000324925.95210.6d","article-title":"Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology","volume":"71","author":"MS Beeri","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/gerona\/60.4.471","article-title":"Type 2 diabetes is negatively associated with Alzheimer\u2019s disease neuropathology","volume":"60","author":"MS Beeri","year":"2005","journal-title":"Journals of Gerontology Series A-Biological Sciences and Medical Sciences"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","article-title":"Insulin resistance predicts brain amyloid deposition in late middle-aged adults","volume":"11","author":"AA Willette","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"161","key":"ref29","first-page":"ra10","article-title":"ER stress inhibits mTORC2 and Akt signaling through GSK-3beta-mediated phosphorylation of rictor","volume":"4","author":"CH Chen","year":"2011","journal-title":"SciSignal"},{"issue":"2","key":"ref30","first-page":"54","article-title":"Does dysregulation of the Notch and wingless\/Wnt pathways underlie the pathogenesis of Alzheimer\u2019s disease?","volume":"6","author":"BH Anderton","year":"2000","journal-title":"MolMedToday"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer\u2019s disease","volume":"7","author":"SM de la Monte","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"ref32","first-page":"754","article-title":"Session III: Mechanisms of Age-Related Cognitive Change and Targets for Intervention: Inflammatory, Oxidative, and Metabolic Processes","volume":"67","author":"S Craft","year":"2012","journal-title":"JGerontolA BiolSciMedSci"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuropharm.2011.06.003","article-title":"Insulin promotes dendritic spine and synapse formation by the PI3K\/Akt\/mTOR and Rac1 signaling pathways","volume":"61","author":"CC Lee","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","article-title":"High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice","volume":"67","author":"SE Arnold","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200822010-00001","article-title":"The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer\u2019s disease: therapeutic implications","volume":"22","author":"Q Jiang","year":"2008","journal-title":"CNS Drugs"},{"issue":"2","key":"ref36","first-page":"209","article-title":"Targeting PPARbeta\/delta for the treatment of type 2 diabetes mellitus","volume":"16","author":"L Salvado","year":"2012","journal-title":"ExpertOpinTherTargets"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-5-36","article-title":"Increased expression of RXRalpha in dementia: an early harbinger for the cholesterol dyshomeostasis?","volume":"5","author":"A Akram","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"3","key":"ref38","first-page":"352","article-title":"PGC-1 alpha Expression Decreases in the Alzheimer Disease Brain as a Function of Dementia","volume":"66","author":"WP Qin","year":"2009","journal-title":"Archives of Neurology"},{"issue":"4","key":"ref39","first-page":"205","article-title":"Insulin signaling in the central nervous system: learning to survive","volume":"79","author":"LP van der Heide","year":"2006","journal-title":"ProgNeurobiol"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.2337\/db14-0340","article-title":"Insulin regulates brain function, but how does it get there?","volume":"63","author":"SM Gray","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","article-title":"Diabetes is related to cerebral infarction but not to AD pathology in older persons","volume":"67","author":"Z Arvanitakis","year":"2006","journal-title":"Neurology"},{"issue":"353","key":"ref42","article-title":""White Paper" meeting summary and catalyst for future inquiry: Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction","volume":"5","author":"L Stoeckel","year":"2016","journal-title":"F1000Research"},{"key":"ref43","first-page":"88","article-title":"Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia","volume":"6","author":"TM Hsu","year":"2014","journal-title":"Frontiers in aging neuroscience"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"L Xie","year":"2002","journal-title":"J Neurosci"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"FG De Felice","year":"2009","journal-title":"ProcNatlAcad Sci US A"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneurol.2012.112","article-title":"Alzheimer disease: Insulin resistance and AD\u2014extending the translational path","volume":"8","author":"S Craft","year":"2012","journal-title":"Nature reviews Neurology"},{"key":"ref47","first-page":"321280","article-title":"Insulin receptor expression and activity in the brains of nondiabetic sporadic Alzheimer\u2019s disease cases","volume":"2012","author":"L Ho","year":"2012","journal-title":"IntJAlzheimersDis"},{"issue":"4","key":"ref48","first-page":"1316","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"K Talbot","year":"2012","journal-title":"JClinInvest"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","article-title":"Blood-brain barrier permeability in Alzheimer\u2019s disease: a case-control MRI study","volume":"171","author":"JM Starr","year":"2009","journal-title":"Psychiatry Res"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease","volume":"118","author":"RD Bell","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"RD Bell","year":"2007","journal-title":"JCerebBlood Flow Metab"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration","volume":"28","author":"BV Zlokovic","year":"2005","journal-title":"Trends Neurosci"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10571-015-0308-1","article-title":"Microvascular Dysfunction and Cognitive Impairment","volume":"36","author":"TM De Silva","year":"2016","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"JM Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic Microvascular Disease: An Endocrine Society Scientific Statement","volume":"102","author":"EJ Barrett","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"ref56","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease","volume":"11","author":"HM Snyder","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"Pt 4","key":"ref57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/brain\/awv025","article-title":"Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer\u2019s disease and vascular dementia","volume":"138","author":"T Thomas","year":"2015","journal-title":"Brain"},{"issue":"9","key":"ref58","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"PB Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00401-010-0654-5","article-title":"Prevalence of dementia disorders in the oldest-old: an autopsy study","volume":"119","author":"KA Jellinger","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref60","article-title":"Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study","author":"C Brayne","year":"2009","journal-title":"JAlzheimers Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/STROKEAHA.108.530337","article-title":"Interhemispheric Distribution of Alzheimer Disease and Vascular Pathology in Brain Aging","volume":"40","author":"P Giannakopoulos","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-006-0144-y","article-title":"Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience","volume":"113","author":"P Giannakopoulos","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"3","key":"ref63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.jnen.0000203077.53080.2c","article-title":"Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status","volume":"65","author":"C Bouras","year":"2006","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"ref64","first-page":"467","article-title":"Hippocampal microvasculature attrition and cognitive decline in Alzheimers disease","author":"TL Bailey","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease\u2014A review of endothelium-mediated mechanisms and ensuing vicious circles","volume":"82","author":"LY Di Marco","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2353\/ajpath.2010.090482","article-title":"Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer\u2019s disease mutations","volume":"176","author":"MA Gama Sosa","year":"2010","journal-title":"Am J Pathol"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/jcbfm.2011.43","article-title":"Neurovascular function in Alzheimer\u2019s disease patients and experimental models","volume":"31","author":"N Nicolakakis","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"ref68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11892-014-0541-x","article-title":"Microvascular dysfunction in the context of diabetic neuropathy","volume":"14","author":"A Stirban","year":"2014","journal-title":"Curr Diab Rep"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00125-014-3461-z","article-title":"The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy","volume":"58","author":"L Ostergaard","year":"2015","journal-title":"Diabetologia"},{"issue":"5","key":"ref70","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1039\/C4IB00296B","article-title":"Systems biology of the microvasculature","volume":"7","author":"LE Clegg","year":"2015","journal-title":"Integr Biol (Camb)"},{"issue":"7","key":"ref71","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","article-title":"Endothelial cell metabolism in normal and diseased vasculature","volume":"116","author":"G Eelen","year":"2015","journal-title":"Circ Res"},{"issue":"1\u20132","key":"ref72","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02935589","article-title":"Insulin and insulin-like growth factor receptors in the nervous system","volume":"3","author":"M Adamo","year":"1989","journal-title":"Mol Neurobiol"},{"issue":"10","key":"ref73","doi-asserted-by":"crossref","first-page":"e7642","DOI":"10.1371\/journal.pone.0007642","article-title":"Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals","volume":"4","author":"P Katsel","year":"2009","journal-title":"PLoS One"},{"key":"ref74","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing Transcriptome and splicing database of Glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Y Zhang","year":"2014","journal-title":"J Neurosci"},{"issue":"4","key":"ref75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neurobiolaging.2007.07.021","article-title":"Transcriptional vulnerability of brain regions in Alzheimer\u2019s disease and dementia","volume":"30","author":"V Haroutunian","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"1","key":"ref76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","article-title":"Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease","volume":"8","author":"M Wang","year":"2016","journal-title":"Genome Med"},{"key":"ref77","article-title":"Step-gradient isolation of the adult mammalian brain microvasculature through a layer of Ficoll-Paque PLUS","author":"M Gama-Sosa","year":"2016","journal-title":"Microvascular Research"},{"issue":"6","key":"ref78","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archneur.56.6.713","article-title":"Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease","volume":"56","author":"V Haroutunian","year":"1999","journal-title":"Arch Neurol"},{"issue":"9","key":"ref79","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","article-title":"Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease","volume":"55","author":"V Haroutunian","year":"1998","journal-title":"Arch Neurol"},{"issue":"4","key":"ref80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"SS Mirra","year":"1991","journal-title":"Neurology"},{"issue":"5","key":"ref81","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbadis.2015.11.013","article-title":"The role of insulin in the vascular contributions to age-related dementia","volume":"1862","author":"TM Hughes","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"ref82","first-page":"29","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"S Craft","year":"2012","journal-title":"ArchNeurol"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"EA Winkler","year":"2015","journal-title":"Nat Neurosci"},{"issue":"7","key":"ref84","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.neurobiolaging.2014.01.138","article-title":"Non-viability of crossing the Alzheimer mouse model Tg2576 with the type 2 diabetes mouse model ob\/ob","volume":"35","author":"I Lubitz","year":"2014","journal-title":"Neurobiol Aging"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40478-016-0282-y","article-title":"Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer\u2019s APP\/PSEN1 mice by gene targeting of diabetes\/Alzheimer\u2019s-related Sorcs1","volume":"4","author":"EM Knight","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"ref86","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.18632\/aging.101004","article-title":"Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates","volume":"8","author":"P Picone","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"ref87","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","article-title":"Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-kappaB activation: Use of insulin to attenuate metformin\u2019s effect","volume":"1853","author":"P Picone","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"ref88","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1073\/pnas.0807991106","article-title":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer\u2019s amyloid peptides via up-regulating BACE1 transcription","volume":"106","author":"Y Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:06:53Z","timestamp":1589040413000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206547"}},"subtitle":[],"editor":[{"given":"Stephen D","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":88,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206547","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}